Literature DB >> 11317642

Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn.

A Endo1, M Ayusawa, M Minato, M Takada, S Takahashi, K Harada.   

Abstract

UNLABELLED: We studied changes in endogenous nitric oxide (NO) synthesis and endothelin-1 (ET-1) production in infants with persistent pulmonary hypertension of the newborn (PPHN). We determined concentrations of serum NO metabolites, i.e., nitrites and nitrates (NOx), and of plasma ET-1 in five infants with PPHN (PPHN group) and in 25 healthy full-term neonates (control group). In both groups, serum NOx concentrations increased over time and plasma ET-1 concentrations decreased with age. The differences in serum NOx concentrations between groups were not significant at < 12 h and 24 h of age; however, they were significantly higher in the PPHN group than in the control group at 5 days of age. The differences in plasma ET-1 concentrations between groups were not significant at 5 days of age, but were significantly higher in the PPHN group than in the control group at < 12 h and 24 h of age.
CONCLUSION: Limited endogenous nitric oxide synthesis and elevated endogenous endothelin-1 production during the first few days of life may contribute to pulmonary hypertension in infants with persistent pulmonary hypertension of the newborn.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317642     DOI: 10.1007/pl00008431

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs.

Authors:  Katherine M Kuniyoshi; Romy S Brock; Bisrat H Gebrekristos; Matthew Abad-Santos; Dinh Hoang; Houchang D Modanlou; Brigham C Willis; Kay D Beharry
Journal:  Am J Transl Res       Date:  2010-06-08       Impact factor: 4.060

Review 2.  Factors relating caesarean section to persistent pulmonary hypertension of the newborn.

Authors:  Niralee Babooa; Wen-Jing Shi; Chao Chen
Journal:  World J Pediatr       Date:  2017-10-20       Impact factor: 2.764

Review 3.  Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management.

Authors:  Enrique M Ostrea; Esterlita T Villanueva-Uy; Girija Natarajan; Herbert G Uy
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Overexpression of cationic amino acid transporter-1 increases nitric oxide production in hypoxic human pulmonary microvascular endothelial cells.

Authors:  Hongmei Cui; Bernadette Chen; Louis G Chicoine; Leif D Nelin
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-12       Impact factor: 2.557

5.  Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPAS.

Authors:  Toshiharu Yamashita; Osamu Ohneda; Masumi Nagano; Motoyuki Iemitsu; Yuichi Makino; Hirotoshi Tanaka; Takashi Miyauchi; Katsutoshi Goto; Kinuko Ohneda; Yoshiaki Fujii-Kuriyama; Lorenz Poellinger; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

6.  Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan.

Authors:  C Goissen; L Ghyselen; P Tourneux; G Krim; L Storme; P Bou; Y Maingourd
Journal:  Eur J Pediatr       Date:  2007-08-15       Impact factor: 3.183

Review 7.  Role of endothelin in uteroplacental circulation and fetal vascular function.

Authors:  Alexandra Paradis; Lubo Zhang
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

8.  Endothelial nitric oxide synthase (NOS) is upregulated in rapid progressive pulmonary hypertension of the newborn.

Authors:  Thomas Hoehn; Anthony A Preston; Allan R McPhaden; Brigitte Stiller; Martin Vogel; Christoph Bührer; Roger M Wadsworth
Journal:  Intensive Care Med       Date:  2003-08-02       Impact factor: 17.440

9.  A randomly-controlled study on the cardiac function at the early stage of return to the plains after short-term exposure to high altitude.

Authors:  Qiquan Zhou; Shengyue Yang; Yongjun Luo; Yushu Qi; Ziqiang Yan; Zifu Shi; Yong Fan
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.